A Trial In Healthy HIV-Negative Women To Assess The Effect Of Menses And Tampon Use On The Pharmacokinetics Of Dapivirine, Delivered By Dapivirine Vaginal Ring-004, Containing 25 Mg Of Dapivirine

NCT02858024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: Dapivirine Vaginal Ring-004 and no tampons
DRUG: Dapivirine Vaginal Ring-004 with tampons
DRUG: Dapivirine Vaginal Ring-004 with no menses
DRUG: Dapivirine Vaginal Ring-004 and same ring inserted after menses
DRUG: Dapivirine Vaginal Ring-004 and new ring inserted after menses

Sponsor

International Partnership for Microbicides, Inc.